Hem › Psoriasisartrit › North Carolina
Kliniska studier för Psoriasisartrit i North Carolina
11 studier för Psoriasisartrit söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
- Onsite Clinical Solutions, Salisbury
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07321873A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
RekryterarFas 1
Ålder 18 och äldre · Kvinnor · Uppdaterad 18 sep. 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accellacare of Hickory, Hickory
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joint and Muscle Research Institute ( Site 5108), Charlotte
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Charlotte
- Clinical Site, Leland
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 11 sep. 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- DJL Clinical Research | Charlotte, NC, Charlotte
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 4
Ålder 18 och äldre · Kvinnor · Uppdaterad 28 aug. 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- och 1 fler
RekryterarObservationsstudie
Upp till ålder 21 · Alla kön · Uppdaterad 27 aug. 2026 · NCT02418442Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
RekryterarObservationsstudie
Alla åldrar · Kvinnor · Uppdaterad 17 juli 2025 · NCT04846959Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.